
For decades, the field focused on the plaques and tangles of misfolded proteins that show up in the brains of patients with Alzheimer’s, Parkinson’s and other disorders. The natural assumption was that if you could design a drug to clear out that gunk, you could save the brain. But so far, that bet hasn't paid off. Now, researchers are taking a big step back and asking whether the plaques aren't a culprit, but rather a clue pointing to something more fundamental going wrong in our brain cells...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Is chronic fatigue a gut-brain reflex? | Julia Kaltschmidt

A new precision neuroscience of language (Big Ideas in Neuroscience) | Cory Shain

How childhood (and Pokémon) shape how we see the world | Kalanit Grill-Spector

The FDA's psychedelic sea-change: what accelerated clinical trials for psilocybin, methylone, and ibogaine mean for mental health and neuroscience research | Boris Heifets
Free AI-powered recaps of From Our Neurons to Yours and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.